Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab

Lignende værker

• Adalimumab Treatment in Biologically Naïve Crohn’s Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement
  af: Tsutomu Mizoshita, et al.
  Udgivet: (2014-01-01)
• Adalimumab Treatment in Biologically Naïve Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement
  af: Mizoshita, Tsutomu, et al.
  Udgivet: (2014)
• Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases
  af: Tanida, Satoshi, et al.
  Udgivet: (2016)
• Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy
  af: Mizoshita, Tsutomu, et al.
  Udgivet: (2017)
• The First Case of Biological Therapy Discontinuation After a Complete Remission Induced by Maintenance Therapy With Adalimumab for Refractory Ulcerative Colitis
  af: Tanida, Satoshi, et al.
  Udgivet: (2015)